CLINICAL_TRIALS
trial_result
· 2018-05-08
Clinical Trial Update: Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes. [Phase 3]
Summary
A phase 3 trial comparing semaglutide to dulaglutide as add-on to metformin in type 2 diabetes; results completed with posted findings in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2018-05-08